Eli Lilly and Co., US5324571083

Eli Lilly stock after-hours at EUR 1029.40: plus 0.83 percent versus Lang & Schwarz prior close

Published on 10/06/2026 at 20:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Eli Lilly stock was at EUR 1029.40 after-hours at 8:52 p.m. CEST on October 6, 2026, up plus 0.83 percent versus the Lang & Schwarz prior close. Lilly will present 21 dermatology posters.

Bauhaus-Poster mit geometrischen Formen und dem Wort PHARMA in Rot und Blau
Bauhaus-Poster mit geometrischen Formen repräsentiert Eli Lilly and Company, ISIN US5324571083, im Pharmasektor gestalterisch, Illustration mit AI erstellt.

Eli Lilly stock was at EUR 1029.40 after-hours at 8:52 p.m. CEST on October 6, 2026, according to Lang & Schwarz. The price was plus 0.83 percent versus the prior close at Lang & Schwarz.

After-hours trading

The prior close at Lang & Schwarz was EUR 1020.90. The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CEST is shown by the continuously updated real-time quote of Eli Lilly stock.

Lilly plans dermatology presentations

In a release dated October 5, 2026, Eli Lilly and Company said it will present 21 posters at the Fall Clinical Dermatology Conference in Las Vegas from October 8 through October 11. The program includes 13 presentations on EBGLYSS for moderate-to-severe atopic dermatitis, six presentations on concomitant Taltz and Zepbound use in psoriasis and obesity or overweight, and presentations on Olumiant in pediatric alopecia areata.

Jaypirca indication expanded

In a separate October 2 release, Eli Lilly and Company said the U.S. Food and Drug Administration approved an additional indication for Jaypirca in adults with previously untreated chronic lymphocytic leukemia or small lymphocytic lymphoma who have no known 17p deletion. The approval permits Jaypirca to be used as a first-line treatment for appropriate patients.

Disclaimer...

en | US5324571083 | ELI LILLY AND CO. | boerse | 70245708 | bgmi